RxDoctor Payments Data

Craig Hoffman

Medical · Oskaloosa, IANPI 1508848912

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Boston Scientific at 31.7% of the total. Reporting peaked in 2024 at $1,174 and has fallen 53.2% since, to $550 in 2025.

$3,566in general payments, 2019–2025

Across 148 payments — averaging $24.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Medtronic$731
  • Abbott$608
  • Philips North America LLC$337
  • Impulse Dynamics (USA) Inc.$208
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$182
  • plus $370 from 3 others

What the payments were for

  • Food & beverage$3,566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,566 in reported general payments places this provider in the 85th percentile of 141 medical providers in Iowa.

See all medical providers in Iowa

Medicare billing

Part B allowed, 2024
$76,174
Medicare patients
849
Services billed
2,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban999$860,580
XareltoRivaroxaban382$323,921
Dofetilide92$20,191
Flecainide Acetate429$16,210
Metoprolol Succinate1,071$10,763
Amiodarone Hcl768$8,563
SotalolSotalol Hcl398$6,618
CorlanorIvabradine Hcl11$6,455
Propafenone Hcl154$5,629
Midodrine Hcl36$4,798
Diltiazem 12hr ErDiltiazem Hcl18$4,416
Diltiazem 24hr Er (Cd)Diltiazem Hcl192$3,779
Bisoprolol Fumarate105$3,218
Potassium Chloride171$2,032
Losartan Potassium233$1,961

Paid to pharmacies, not to this prescriber.

Other medical in Oskaloosa

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →